Expression, regulation and function of intestinal drug transporters: an update

References

Artursson, P. (1990). Epithelial transport of drugs in cell culture. I: a model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. J. Pharm. Sci. 79, 476–482.10.1002/jps.2600790604Search in Google Scholar PubMed

Bailey, D.G. (2010). Fruit juice inhibition of uptake transport: a new type of food-drug interaction. Br. J. Clin. Pharmacol. 70, 645–655.10.1111/j.1365-2125.2010.03722.xSearch in Google Scholar PubMed PubMed Central

Barr, W.H., Zola, E.M., Candler, E.L., Hwang, S.M., Tendolkar, A.V., Shamburek, R., Parker, B., and Hilty, M.D. (1994). Differential absorption of amoxicillin from the human small and large intestine. Clin. Pharmacol. Ther. 56, 279–285.10.1038/clpt.1994.138Search in Google Scholar PubMed

Berggren, S., Gall, C., Wollnitz, N., Ekelund, M., Karlbom, U., Hoogstraate, J., Schrenk, D., and Lennernas, H. (2007). Gene and protein expression of P-glycoprotein, MRP1, MRP2, and CYP3A4 in the small and large human intestine. Mol. Pharm. 4, 252–257.10.1021/mp0600687Search in Google Scholar PubMed

Bexten, M., Oswald, S., Grube, M., Jia, J., Graf, T., Zimmermann, U., Rodewald, K., Zolk, O., Schwantes, U., Siegmund, W., et al. (2015). Expression of drug transporters and drug metabolizing enzymes in the bladder urothelium in man and affinity of the bladder spasmolytic trospium chloride to transporters likely involved in its pharmacokinetics. Mol. Pharm. 12, 171–178.10.1021/mp500532xSearch in Google Scholar PubMed

Brandsch, M. (2013). Drug transport via the intestinal peptide transporter PepT1. Curr. Opin. Pharmacol. 13, 881–887.10.1016/j.coph.2013.08.004Search in Google Scholar PubMed

Brill, S.S., Furimsky, A.M., Ho, M.N., Furniss, M.J., Li, Y., Green, A.G., Bradford, W.W., Green, C.E., Kapetanovic, I.M., and Iyer, L.V. (2006). Glucuronidation of trans-resveratrol by human liver and intestinal microsomes and UGT isoforms. J. Pharm. Pharmacol. 58, 469–479.10.1211/jpp.58.4.0006Search in Google Scholar PubMed

Brouwer, K.L., Keppler, D., Hoffmaster, K.A., Bow, D.A., Cheng, Y., Lai, Y., Palm, J.E., Stieger, B., and Evers, R. (2013). In vitro methods to support transporter evaluation in drug discovery and development. Clin. Pharmacol. Ther. 94, 95–112.10.1038/clpt.2013.81Search in Google Scholar PubMed

Brueck, S., Strohmeier, J., Busch, D., Drozdzik, M., and Oswald, S. (2016). Caco-2 cells-expression, regulation and function of drug transporters compared to human jejunal tissue. Biopharm. Drug Dispos. doi: 10.1002/bdd.2025. [Epub ahead of print].Search in Google Scholar PubMed

Bruyere, A., Decleves, X., Bouzom, F., Ball, K., Marques, C., Treton, X., Pocard, M., Valleur, P., Bouhnik, Y., Panis, Y., et al. (2010). Effect of variations in the amounts of P-glycoprotein (ABCB1), BCRP (ABCG2) and CYP3A4 along the human small intestine on PBPK models for predicting intestinal first pass. Mol. Pharm. 7, 1596–1607.10.1021/mp100015xSearch in Google Scholar PubMed

Burk, O., Arnold, K.A., Geick, A., Tegude, H., and Eichelbaum, M. (2005). A role for constitutive androstane receptor in the regulation of human intestinal MDR1 expression. Biol. Chem. 386, 503–513.10.1515/BC.2005.060Search in Google Scholar PubMed

Chan, L.M., Lowes, S., and Hirst, B.H. (2004). The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability. Eur. J. Pharm. Sci. 21, 25–51.10.1016/j.ejps.2003.07.003Search in Google Scholar PubMed

Cohen, A.F., Kroon, R., Schoemaker, H.C., Breimer, D.D., Van Vliet-Verbeek, A., and Brandenburg, H.C. (1993). The bioavailability of digoxin from three oral formulations measured by a specific HPLC assay. Br. J. Clin. Pharmacol. 35, 136–142.10.1111/j.1365-2125.1993.tb05679.xSearch in Google Scholar PubMed PubMed Central

Cortvriendt, W.R., Verschoor, J.S., and Hespe, W. (1987). Bioavailability study of a new amoxicillin tablet designed for several modes of oral administration. Arzneimittelforschung 37, 977–979.Search in Google Scholar

Cui, Y., Konig, J., and Keppler, D. (2001). Vectorial transport by double-transfected cells expressing the human uptake transporter SLC21A8 and the apical export pump ABCC2. Mol. Pharmacol. 60, 934–943.10.1124/mol.60.5.934Search in Google Scholar PubMed

Custodio, J.M., Wu, C.Y., and Benet, L.Z. (2008). Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption. Adv. Drug Deliv. Rev. 60, 717–733.10.1016/j.addr.2007.08.043Search in Google Scholar PubMed PubMed Central

Dahlgren, D., Roos, C., Sjogren, E., and Lennernas, H. (2015). Direct in vivo human intestinal permeability (Peff) determined with different clinical perfusion and intubation methods. J. Pharm. Sci. 104, 2702–2726.10.1002/jps.24258Search in Google Scholar PubMed

Dawson, P.A. (2011). Role of the intestinal bile acid transporters in bile acid and drug disposition. Handb. Exp. Pharmacol. 169–203.10.1007/978-3-642-14541-4_4Search in Google Scholar PubMed PubMed Central

de Waart, D.R., Vlaming, M.L., Kunne, C., Schinkel, A.H., and Oude Elferink, R.P. (2009). Complex pharmacokinetic behavior of ezetimibe depends on abcc2, abcc3, and abcg2. Drug Metab. Dispos. 37, 1698–1702.10.1124/dmd.108.026146Search in Google Scholar PubMed

de Waart, D.R., van de Wetering, K., Kunne, C., Duijst, S., Paulusma, C.C., and Oude Elferink, R.P. (2012). Oral availability of cefadroxil depends on ABCC3 and ABCC4. Drug Metab. Dispos. 40, 515–521.10.1124/dmd.111.041731Search in Google Scholar PubMed

de, l., Brunner, M., Eichler, H.G., Rehak, E., Gross, J., Thyroff-Friesinger, U., Muller, M., and Derendorf, H. (2002). Comparative target site pharmacokinetics of immediate- and modified-release formulations of cefaclor in humans. J. Clin. Pharmacol. 42, 403–411.10.1177/00912700222011454Search in Google Scholar PubMed

Deeley, R.G., Westlake, C., and Cole, S.P. (2006). Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins. Physiol. Rev. 86, 849–899.10.1152/physrev.00035.2005Search in Google Scholar PubMed

Di, L., Whitney-Pickett, C., Umland, J.P., Zhang, H., Zhang, X., Gebhard, D.F., Lai, Y., Federico, J.J., III, Davidson, R.E., Smith, R., et al. (2011). Development of a new permeability assay using low-efflux MDCKII cells. J. Pharm. Sci. 100, 4974–4985.10.1002/jps.22674Search in Google Scholar PubMed

Di, L., Artursson, P., Avdeef, A., Ecker, G.F., Faller, B., Fischer, H., Houston, J.B., Kansy, M., Kerns, E.H., Kramer, S.D., et al. (2012). Evidence-based approach to assess passive diffusion and carrier-mediated drug transport. Drug Discov. Today 17, 905–912.10.1016/j.drudis.2012.03.015Search in Google Scholar PubMed

Dresser, G.K., Bailey, D.G., Leake, B.F., Schwarz, U.I., Dawson, P.A., Freeman, D.J., and Kim, R.B. (2002). Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. Clin. Pharmacol. Ther. 71, 11–20.10.1067/mcp.2002.121152Search in Google Scholar PubMed

Drozdzik, M., Groer, C., Penski, J., Lapczuk, J., Ostrowski, M., Lai, Y.R., Prasad, B., Unadkat, J.D., Siegmund, W., and Oswald, S. (2014). Protein abundance of clinically relevant multidrug transporters along the entire length of the human intestine. Mol. Pharmaceut. 11, 3547–3555.10.1021/mp500330ySearch in Google Scholar PubMed

Edwards, A. and Ensom, M.H. (2012). Pharmacokinetic effects of bariatric surgery. Ann. Pharmacother. 46, 130–136.10.1345/aph.1Q414Search in Google Scholar PubMed

Elsby, R., Martin, P., Surry, D., Sharma, P., and Fenner, K. (2016). Solitary inhibition of the breast cancer resistance protein efflux transporter results in a clinically significant drug-drug interaction with rosuvastatin by causing up to a 2-fold increase in statin exposure. Drug Metab. Dispos. 44, 398–408.10.1124/dmd.115.066795Search in Google Scholar PubMed

Endres, C.J., Hsiao, P., Chung, F.S., and Unadkat, J.D. (2006). The role of transporters in drug interactions. Eur. J. Pharm. Sci. 27, 501–517.10.1016/j.ejps.2005.11.002Search in Google Scholar PubMed

Englund, G., Rorsman, F., Ronnblom, A., Karlbom, U., Lazorova, L., Grasjo, J., Kindmark, A., and Artursson, P. (2006). Regional levels of drug transporters along the human intestinal tract: co-expression of ABC and SLC transporters and comparison with Caco-2 cells. Eur. J. Pharm. Sci. 29, 269–277.10.1016/j.ejps.2006.04.010Search in Google Scholar PubMed

Englund, G., Jacobson, A., Rorsman, F., Artursson, P., Kindmark, A., and Ronnblom, A. (2007). Efflux transporters in ulcerative colitis: decreased expression of BCRP (ABCG2) and Pgp (ABCB1). Inflamm. Bowel. Dis. 13, 291–297.10.1002/ibd.20030Search in Google Scholar PubMed

Estudante, M., Morais, J.G., Soveral, G., and Benet, L.Z. (2013). Intestinal drug transporters: an overview. Adv. Drug Deliv. Rev. 65, 1340–1356.10.1016/j.addr.2012.09.042Search in Google Scholar

Fromm, M.F., Kauffmann, H.M., Fritz, P., Burk, O., Kroemer, H.K., Warzok, R.W., Eichelbaum, M., Siegmund, W., and Schrenk, D. (2000). The effect of rifampin treatment on intestinal expression of human MRP transporters. Am. J. Pathol. 157, 1575–1580.10.1016/S0002-9440(10)64794-3Search in Google Scholar

Gartzke, D. and Fricker, G. (2014). Establishment of optimized MDCK cell lines for reliable efflux transport studies. J. Pharm. Sci. 103, 1298–1304.10.1002/jps.23901Search in Google Scholar

Gartzke, D., Delzer, J., Laplanche, L., Uchida, Y., Hoshi, Y., Tachikawa, M., Terasaki, T., Sydor, J., and Fricker, G. (2015). Genomic knockout of endogenous canine P-glycoprotein in wild-type, human P-glycoprotein and human BCRP transfected MDCKII cell lines by zinc finger nucleases. Pharm. Res. 32, 2060–2071.10.1007/s11095-014-1599-5Search in Google Scholar

Geick, A., Eichelbaum, M., and Burk, O. (2001). Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J. Biol. Chem. 276, 14581–14587.10.1074/jbc.M010173200Search in Google Scholar

Giacomini, K.M., Huang, S.M., Tweedie, D.J., Benet, L.Z., Brouwer, K.L., Chu, X., Dahlin, A., Evers, R., Fischer, V., Hillgren, K.M., et al. (2010). Membrane transporters in drug development. Nat. Rev. Drug Discov. 9, 215–236.10.1038/nrd3028Search in Google Scholar

Giacomini, K.M., Balimane, P.V., Cho, S.K., Eadon, M., Edeki, T., Hillgren, K.M., Huang, S.M., Sugiyama, Y., Weitz, D., Wen, Y., et al. (2013). International Transporter Consortium commentary on clinically important transporter polymorphisms. Clin. Pharmacol. Ther. 94, 23–26.10.1038/clpt.2013.12Search in Google Scholar

Glaeser, H., Bailey, D.G., Dresser, G.K., Gregor, J.C., Schwarz, U.I., McGrath, J.S., Jolicoeur, E., Lee, W., Leake, B.F., Tirona, R.G., et al. (2007). Intestinal drug transporter expression and the impact of grapefruit juice in humans. Clin. Pharmacol. Ther. 81, 362–370.10.1038/sj.clpt.6100056Search in Google Scholar

Gomez-Orellana, I. (2005). Strategies to improve oral drug bioavailability. Expert Opin. Drug Deliv. 2, 419–433.10.1517/17425247.2.3.419Search in Google Scholar

Gramatte, T., Oertel, R., Terhaag, B., and Kirch, W. (1996). Direct demonstration of small intestinal secretion and site-dependent absorption of the b-blocker talinolol in humans. Clin. Pharmacol. Ther. 59, 541–549.10.1016/S0009-9236(96)90182-4Search in Google Scholar

Greiner, B., Eichelbaum, M., Fritz, P., Kreichgauer, H.P., von, R.O., Zundler, J., and Kroemer, H.K. (1999). The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin. J. Clin. Invest 104, 147–153.10.1172/JCI6663Search in Google Scholar PubMed PubMed Central

Guo, X., Meng, Q., Liu, Q., Wang, C., Sun, H., Kaku, T., and Liu, K. (2012). Construction, identification and application of HeLa cells stably transfected with human PEPT1 and PEPT2. Peptides 34, 395–403.10.1016/j.peptides.2012.02.009Search in Google Scholar PubMed

Gutmann, H., Hruz, P., Zimmermann, C., Straumann, A., Terracciano, L., Hammann, F., Lehmann, F., Beglinger, C., and Drewe, J. (2008). Breast cancer resistance protein and P-glycoprotein expression in patients with newly diagnosed and therapy-refractory ulcerative colitis compared with healthy controls. Digestion 78, 154–162.10.1159/000179361Search in Google Scholar PubMed

Haenisch, S., Laechelt, S., Bruckmueller, H., Werk, A., Noack, A., Bruhn, O., Remmler, C., and Cascorbi, I. (2011). Down-regulation of ATP-binding cassette C2 protein expression in HepG2 cells after rifampicin treatment is mediated by microRNA-379. Mol. Pharmacol. 80, 314–320.10.1124/mol.110.070714Search in Google Scholar PubMed

Haenisch, S., Werk, A.N., and Cascorbi, I. (2014). MicroRNAs and their relevance to ABC transporters. Br. J. Clin. Pharmacol. 77, 587–596.10.1111/bcp.12251Search in Google Scholar PubMed PubMed Central

Han, J.Y., Lim, H.S., Yoo, Y.K., Shin, E.S., Park, Y.H., Lee, S.Y., Lee, J.E., Lee, D.H., Kim, H.T., and Lee, J.S. (2007). Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer. Cancer 110, 138–147.10.1002/cncr.22760Search in Google Scholar PubMed

Han, T.K., Everett, R.S., Proctor, W.R., Ng, C.M., Costales, C.L., Brouwer, K.L., and Thakker, D.R. (2013). Organic cation transporter 1 (OCT1/mOct1) is localized in the apical membrane of Caco-2 cell monolayers and enterocytes. Mol. Pharmacol. 84, 182–189.10.1124/mol.112.084517Search in Google Scholar PubMed PubMed Central

Harbourt, D.E., Fallon, J.K., Ito, S., Baba, T., Ritter, J.K., Glish, G.L., and Smith, P.C. (2012). Quantification of human uridine-diphosphate glucuronosyl transferase 1A isoforms in liver, intestine, and kidney using nanobore liquid chromatography-tandem mass spectrometry. Anal. Chem. 84, 98–105.10.1021/ac201704aSearch in Google Scholar PubMed PubMed Central

Hartter, S., Koenen-Bergmann, M., Sharma, A., Nehmiz, G., Lemke, U., Timmer, W., and Reilly, P.A. (2012). Decrease in the oral bioavailability of dabigatran etexilate after co-medication with rifampicin. Br. J. Clin. Pharmacol. 74, 490–500.10.1111/j.1365-2125.2012.04218.xSearch in Google Scholar PubMed PubMed Central

Hartter, S., Sennewald, R., Nehmiz, G., and Reilly, P. (2013). Oral bioavailability of dabigatran etexilate (Pradaxa^®) after co-medication with verapamil in healthy subjects. Br. J. Clin. Pharmacol. 75, 1053–1062.10.1111/j.1365-2125.2012.04453.xSearch in Google Scholar PubMed PubMed Central

Harwood, M.D., Neuhoff, S., Carlson, G.L., Warhurst, G., and Rostami-Hodjegan, A. (2013). Absolute abundance and function of intestinal drug transporters: a prerequisite for fully mechanistic in vitro-in vivo extrapolation of oral drug absorption. Biopharm. Drug Dispos. 34, 2–28.10.1002/bdd.1810Search in Google Scholar PubMed

Hayeshi, R., Hilgendorf, C., Artursson, P., Augustijns, P., Brodin, B., Dehertogh, P., Fisher, K., Fossati, L., Hovenkamp, E., Korjamo, T., et al. (2008). Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories. Eur. J. Pharm. Sci. 35, 383–396.10.1016/j.ejps.2008.08.004Search in Google Scholar PubMed

Hediger, M.A., Clemencon, B., Burrier, R.E., and Bruford, E.A. (2013). The ABCs of membrane transporters in health and disease (SLC series): introduction. Mol. Aspects Med. 34, 95–107.10.1016/j.mam.2012.12.009Search in Google Scholar PubMed PubMed Central

Hilgendorf, C., Ahlin, G., Seithel, A., Artursson, P., Ungell, A.L., and Karlsson, J. (2007). Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines. Drug Metab. Dispos. 35, 1333–1340.10.1124/dmd.107.014902Search in Google Scholar PubMed

Hillgren, K.M., Keppler, D., Zur, A.A., Giacomini, K.M., Stieger, B., Cass, C.E., and Zhang, L. (2013). Emerging transporters of clinical importance: an update from the International Transporter Consortium. Clin. Pharmacol. Ther. 94, 52–63.10.1038/clpt.2013.74Search in Google Scholar PubMed

Holtbecker, N., Fromm, M.F., Kroemer, H.K., Ohnhaus, E.E., and Heidemann, H. (1996). The nifedipine-rifampin interaction. Evidence for induction of gut wall metabolism. Drug Metab. Dispos. 24, 1121–1123.10.1016/S0090-9556(25)08415-6Search in Google Scholar

Hubatsch, I., Ragnarsson, E.G., and Artursson, P. (2007). Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers. Nat. Protoc. 2, 2111–2119.10.1038/nprot.2007.303Search in Google Scholar PubMed

Ikemura, K., Iwamoto, T., and Okuda, M. (2014). MicroRNAs as regulators of drug transporters, drug-metabolizing enzymes, and tight junctions: implication for intestinal barrier function. Pharmacol. Ther. 143, 217–224.10.1016/j.pharmthera.2014.03.002Search in Google Scholar PubMed

Jeong, E.J., Liu, X., Jia, X., Chen, J., and Hu, M. (2005). Coupling of conjugating enzymes and efflux transporters: impact on bioavailability and drug interactions. Curr. Drug Metab. 6, 455–468.10.2174/138920005774330657Search in Google Scholar PubMed

Jia, J., Puls, D., Oswald, S., Jedlitschky, G., Kuhn, J.P., Weitschies, W., Hosten, N., Siegmund, W., and Keiser, M. (2014). Characterization of the intestinal and hepatic uptake/efflux transport of the magnetic resonance imaging contrast agent gadolinium-ethoxylbenzyl-diethylenetriamine-pentaacetic acid. Invest. Radiol. 49, 78–86.10.1097/RLI.0b013e3182a70043Search in Google Scholar PubMed

Jigorel, E., Le, V.M., Boursier-Neyret, C., Parmentier, Y., and Fardel, O. (2006). Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drug-sensing receptors in primary human hepatocytes. Drug Metab. Dispos. 34, 1756–1763.10.1124/dmd.106.010033Search in Google Scholar PubMed

Kemp, D.C., Fan, P.W., and Stevens, J.C. (2002). Characterization of raloxifene glucuronidation in vitro: contribution of intestinal metabolism to presystemic clearance. Drug Metab. Dispos. 30, 694–700.10.1124/dmd.30.6.694Search in Google Scholar PubMed

Keppler, D. (2014). The Roles of MRP2, MRP3, and OATP1B1 and OATP1B3 in conjugated hyperbilirubinemia. Drug Metab. Dispos. 42, 561–565.10.1124/dmd.113.055772Search in Google Scholar PubMed

Klaassen, C.D. and Aleksunes, L.M. (2010). Xenobiotic, bile acid, and cholesterol transporters: function and regulation. Pharmacol. Rev. 62, 1–96.10.1124/pr.109.002014Search in Google Scholar PubMed PubMed Central

Klaassen, C.D. and Slitt, A.L. (2005). Regulation of hepatic transporters by xenobiotic receptors. Curr. Drug Metab. 6, 309–328.10.2174/1389200054633826Search in Google Scholar PubMed

Kobayashi, D., Nozawa, T., Imai, K., Nezu, J., Tsuji, A., and Tamai, I. (2003). Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport across intestinal apical membrane. J. Pharmacol. Exp. Ther. 306, 703–708.10.1124/jpet.103.051300Search in Google Scholar PubMed

Konig, J., Muller, F., and Fromm, M.F. (2013). Transporters and drug-drug interactions: important determinants of drug disposition and effects. Pharmacol. Rev. 65, 944–966.10.1124/pr.113.007518Search in Google Scholar PubMed

Kramer, W. (2011). Transporters, Trojan horses and therapeutics: suitability of bile acid and peptide transporters for drug delivery. Biol. Chem. 392, 77–94.10.1515/bc.2011.017Search in Google Scholar

Kullak-Ublick, G.A., Ismair, M.G., Stieger, B., Landmann, L., Huber, R., Pizzagalli, F., Fattinger, K., Meier, P.J., and Hagenbuch, B. (2001). Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology 120, 525–533.10.1053/gast.2001.21176Search in Google Scholar PubMed

Kusuhara, H., Furuie, H., Inano, A., Sunagawa, A., Yamada, S., Wu, C., Fukizawa, S., Morimoto, N., Ieiri, I., Morishita, M., et al. (2012). Pharmacokinetic interaction study of sulphasalazine in healthy subjects and the impact of curcumin as an in vivo inhibitor of BCRP. Br. J. Pharmacol. 166, 1793–1803.10.1111/j.1476-5381.2012.01887.xSearch in Google Scholar PubMed PubMed Central

Kuteykin-Teplyakov, K., Luna-Tortos, C., Ambroziak, K., and Loscher, W. (2010). Differences in the expression of endogenous efflux transporters in MDR1-transfected versus wildtype cell lines affect P-glycoprotein mediated drug transport. Br. J. Pharmacol. 160, 1453–1463.10.1111/j.1476-5381.2010.00801.xSearch in Google Scholar PubMed PubMed Central

Lau, Y.Y., Okochi, H., Huang, Y., and Benet, L.Z. (2006). Multiple transporters affect the disposition of atorvastatin and its two active hydroxy metabolites: application of in vitro and ex situ systems. J. Pharmacol. Exp. Ther. 316, 762–771.10.1124/jpet.105.093088Search in Google Scholar PubMed

Lennernas, H. (2003). Clinical pharmacokinetics of atorvastatin. Clin. Pharmacokinet. 42, 1141–1160.10.2165/00003088-200342130-00005Search in Google Scholar PubMed

Lin, J.H., Chiba, M., and Baillie, T.A. (1999). Is the role of the small intestine in first-pass metabolism overemphasized? Pharmacol. Rev. 51, 135–158.Search in Google Scholar

Matsushima, S., Maeda, K., Kondo, C., Hirano, M., Sasaki, M., Suzuki, H., and Sugiyama, Y. (2005). Identification of the hepatic efflux transporters of organic anions using double-transfected Madin-Darby canine kidney II cells expressing human organic anion-transporting polypeptide 1B1 (OATP1B1)/multidrug resistance-associated protein 2, OATP1B1/multidrug resistance 1, and OATP1B1/breast cancer resistance protein. J. Pharmacol. Exp. Ther. 314, 1059–1067.10.1124/jpet.105.085589Search in Google Scholar PubMed

Meier, Y., Eloranta, J.J., Darimont, J., Ismair, M.G., Hiller, C., Fried, M., Kullak-Ublick, G.A., and Vavricka, S.R. (2007). Regional distribution of solute carrier mRNA expression along the human intestinal tract. Drug Metab. Dispos. 35, 590–594.10.1124/dmd.106.013342Search in Google Scholar PubMed

Meyer zu Schwabedissen, H.E., Oswald, S., Bresser, C., Nassif, A., Modess, C., Desta, Z., Ogburn, E.T., Marinova, M., Lutjohann, D., Spielhagen, C., et al. (2012). Compartment-specific gene regulation of the CAR inducer efavirenz in vivo. Clin. Pharmacol. Ther. 92, 103–111.10.1038/clpt.2012.34Search in Google Scholar PubMed PubMed Central

Miksits, M., Maier-Salamon, A., Aust, S., Thalhammer, T., Reznicek, G., Kunert, O., Haslinger, E., Szekeres, T., and Jaeger, W. (2005). Sulfation of resveratrol in human liver: evidence of a major role for the sulfotransferases SULT1A1 and SULT1E1. Xenobiotica 35, 1101–1119.10.1080/00498250500354253Search in Google Scholar PubMed

Ming, X., Knight, B.M., and Thakker, D.R. (2011). Vectorial transport of fexofenadine across Caco-2 cells: involvement of apical uptake and basolateral efflux transporters. Mol. Pharm. 8, 1677–1686.10.1021/mp200026vSearch in Google Scholar PubMed

Misaka, S., Yatabe, J., Muller, F., Takano, K., Kawabe, K., Glaeser, H., Yatabe, M.S., Onoue, S., Werba, J.P., Watanabe, H., et al. (2014). Green tea ingestion greatly reduces plasma concentrations of nadolol in healthy subjects. Clin. Pharmacol. Ther. 95, 432–438.10.1038/clpt.2013.241Search in Google Scholar PubMed

Mitschke, D., Reichel, A., Fricker, G., and Moenning, U. (2008). Characterization of cytochrome P450 protein expression along the entire length of the intestine of male and female rats. Drug Metab. Dispos. 36, 1039–1045.10.1124/dmd.107.019687Search in Google Scholar PubMed

Miura, M., Kagaya, H., Satoh, S., Inoue, K., Saito, M., Habuchi, T., and Suzuki, T. (2008). Influence of drug transporters and UGT polymorphisms on pharmacokinetics of phenolic glucuronide metabolite of mycophenolic acid in Japanese renal transplant recipients. Ther. Drug Monit. 30, 559–564.10.1097/FTD.0b013e3181838063Search in Google Scholar PubMed

Mooij, M.G., de Koning, B.E., Lindenbergh-Kortleve, D.J., Simons-Oosterhuis, Y., van Groen, B.D., Tibboel, D., Samsom, J.N., and de Wildt, S.N. (2016). Human intestinal PEPT1 transporter expression and localization in preterm and term infants. Drug Metab. Dispos. 44, 1014–1019.10.1124/dmd.115.068809Search in Google Scholar PubMed

Morimoto, K., Kishimura, K., Nagami, T., Kodama, N., Ogama, Y., Yokoyama, M., Toda, S., Chiyoda, T., Shimada, R., Inano, A., et al. (2011). Effect of milk on the pharmacokinetics of oseltamivir in healthy volunteers. J. Pharm. Sci. 100, 3854–3861.10.1002/jps.22627Search in Google Scholar PubMed

Mouly, S. and Paine, M.F. (2003). P-glycoprotein increases from proximal to distal regions of human small intestine. Pharm. Res. 20, 1595–1599.10.1023/A:1026183200740Search in Google Scholar

Muller, J., Lips, K.S., Metzner, L., Neubert, R.H., Koepsell, H., and Brandsch, M. (2005). Drug specificity and intestinal membrane localization of human organic cation transporters (OCT). Biochem. Pharmacol. 70, 1851–1860.10.1016/j.bcp.2005.09.011Search in Google Scholar PubMed

Nakamura, K., Hirayama-Kurogi, M., Ito, S., Kuno, T., Yoneyama, T., Obuchi, W., Terasaki, T., and Ohtsuki, S. (2016). Large-scale multiplex absolute protein quantification of drug-metabolizing enzymes and transporters in human intestine, liver, and kidney microsomes by SWATH-MS: comparison with MRM/SRM and HR-MRM/PRM. Proteomics. 16, 2106–2117.10.1002/pmic.201500433Search in Google Scholar PubMed

Nakanishi, T. and Tamai, I. (2015). Interaction of drug or food with drug transporters in intestine and liver. Curr. Drug Metab. 16, 753–764.10.2174/138920021609151201113537Search in Google Scholar PubMed

Nies, A.T., Schwab, M., and Keppler, D. (2008). Interplay of conjugating enzymes with OATP uptake transporters and ABCC/MRP efflux pumps in the elimination of drugs. Expert Opin. Drug Metab. Toxicol. 4, 545–568.10.1517/17425255.4.5.545Search in Google Scholar PubMed

Nozawa, T., Minami, H., Sugiura, S., Tsuji, A., and Tamai, I. (2005). Role of organic anion transporter OATP1B1 (OATP-C) in hepatic uptake of irinotecan and its active metabolite, 7-ethyl-10-hydroxycamptothecin: in vitro evidence and effect of single nucleotide polymorphisms. Drug Metab. Dispos. 33, 434–439.10.1124/dmd.104.001909Search in Google Scholar PubMed

Olander, M., Wisniewski, J.R., Matsson, P., Lundquist, P., and Artursson, P. (2016). The proteome of filter-grown Caco-2 cells with a focus on proteins involved in drug disposition. J. Pharm. Sci. 105, 817–827.10.1016/j.xphs.2015.10.030Search in Google Scholar PubMed

Oscarson, M., Burk, O., Winter, S., Schwab, M., Wolbold, R., Dippon, J., Eichelbaum, M., and Meyer, U.A. (2007). Effects of rifampicin on global gene expression in human small intestine. Pharmacogenet. Genomics 17, 907–918.10.1097/FPC.0b013e3280143dfcSearch in Google Scholar PubMed

Oswald, S., Giessmann, T., Luetjohann, D., Wegner, D., Rosskopf, D., Weitschies, W., and Siegmund, W. (2006a). Disposition and sterol-lowering effect of ezetimibe are influenced by single-dose coadministration of rifampin, an inhibitor of multidrug transport proteins. Clin. Pharmacol. Ther. 80, 477–485.10.1016/j.clpt.2006.07.006Search in Google Scholar PubMed

Oswald, S., Haenisch, S., Fricke, C., Sudhop, T., Remmler, C., Giessmann, T., Jedlitschky, G., Adam, U., Dazert, E., Warzok, R., et al. (2006b). Intestinal expression of P-glycoprotein (ABCB1), multidrug resistance associated protein 2 (ABCC2), and uridine diphosphate-glucuronosyltransferase 1A1 predicts the disposition and modulates the effects of the cholesterol absorption inhibitor ezetimibe in humans. Clin. Pharmacol. Ther. 79, 206–217.10.1016/j.clpt.2005.11.004Search in Google Scholar PubMed

Oswald, S., Konig, J., Lutjohann, D., Giessmann, T., Kroemer, H.K., Rimmbach, C., Rosskopf, D., Fromm, M.F., and Siegmund, W. (2008). Disposition of ezetimibe is influenced by polymorphisms of the hepatic uptake carrier OATP1B1. Pharmacogenet. Genomics 18, 559–568.10.1097/FPC.0b013e3282fe9a2cSearch in Google Scholar PubMed

Oswald, S., May, K., Rosin, J., Lutjohann, D., and Siegmund, W. (2010). Synergistic influence of Abcb1 and Abcc2 on disposition and sterol lowering effects of ezetimibe in rats. J. Pharmaceut. Sci. 99, 422–429.10.1002/jps.21821Search in Google Scholar PubMed

Oswald, S., Haenisch, S., Ludwig, K., Bernhadt, J., Modess, C., Scheuch, E., Cascorbi, I., and Siegmund, W. (2011). Influence of Roux-En-y gastric bypass surgery on the disposition of paracetamol, talinolol and amoxicillin in obese patients. Clin. Pharmacol. Ther. 89, S29.Search in Google Scholar

Oswald, S., Schwabedissen, H.E.M.Z., Nassif, A., Modess, C., Desta, Z., Ogburn, E.T., Mostertz, J., Keiser, M., Jia, J., Hubeny, A., et al. (2012). Impact of efavirenz on intestinal metabolism and transport: insights from an interaction study with ezetimibe in healthy volunteers. Clin. Pharmacol. Ther. 91, 506–513.10.1038/clpt.2011.255Search in Google Scholar PubMed PubMed Central

Oswald, S., Groer, C., Drozdzik, M., and Siegmund, W. (2013). Mass spectrometry-based targeted proteomics as a tool to elucidate the expression and function of intestinal drug transporters. AAPS J. 15, 1128–1140.10.1208/s12248-013-9521-3Search in Google Scholar PubMed PubMed Central

Paine, M.F., Khalighi, M., Fisher, J.M., Shen, D.D., Kunze, K.L., Marsh, C.L., Perkins, J.D., and Thummel, K.E. (1997). Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism. J. Pharmacol. Exp. Ther. 283, 1552–1562.10.1016/S0022-3565(24)37149-6Search in Google Scholar

Paine, M.F., Hart, H.L., Ludington, S.S., Haining, R.L., Rettie, A.E., and Zeldin, D.C. (2006). The human intestinal cytochrome P450 “pie”. Drug Metab. Dispos. 34, 880–886.10.1124/dmd.105.008672Search in Google Scholar PubMed PubMed Central

Pasanen, M.K., Fredrikson, H., Neuvonen, P.J., and Niemi, M. (2007). Different effects of SLCO1B1 polymorphism on the pharmacokinetics of atorvastatin and rosuvastatin. Clin. Pharmacol. Ther. 82, 726–733.10.1038/sj.clpt.6100220Search in Google Scholar PubMed

Peters, S.A., Jones, C.R., Ungell, A.L., and Hatley, O.J. (2016). Predicting drug extraction in the human gut wall: assessing contributions from drug metabolizing enzymes and transporter proteins using preclinical models. Clin. Pharmacokinet. 55, 673–696.10.1007/s40262-015-0351-6Search in Google Scholar PubMed PubMed Central

Phan, D.D., Chin-Hong, P., Lin, E.T., Anderle, P., Sadee, W., and Guglielmo, B.J. (2003). Intra- and interindividual variabilities of valacyclovir oral bioavailability and effect of coadministration of an hPEPT1 inhibitor. Antimicrob. Agents Chemother. 47, 2351–2353.10.1128/AAC.47.7.2351-2353.2003Search in Google Scholar PubMed PubMed Central

Planas, J.M., Alfaras, I., Colom, H., and Juan, M.E. (2012). The bioavailability and distribution of trans-resveratrol are constrained by ABC transporters. Arch. Biochem. Biophys. 527, 67–73.10.1016/j.abb.2012.06.004Search in Google Scholar PubMed

Prasad, B. and Unadkat, J.D. (2014). Optimized approaches for quantification of drug transporters in tissues and cells by MRM proteomics. AAPS J. 16, 634–648.10.1208/s12248-014-9602-ySearch in Google Scholar PubMed PubMed Central

Proctor, W.R., Ming, X., Bourdet, D., Han, T.K., Everett, R.S., and Thakker, D.R. (2016). Why does the intestine lack basolateral efflux transporters for cationic compounds? A provocative hypothesis. J. Pharm. Sci. 105, 484–496.10.1016/j.xphs.2015.11.040Search in Google Scholar PubMed

Qiu, X., Zhang, H., and Lai, Y. (2014). Quantitative targeted proteomics for membrane transporter proteins: method and application. AAPS J. 16, 714–726.10.1208/s12248-014-9607-6Search in Google Scholar PubMed PubMed Central

Rae, J.M., Johnson, M.D., Lippman, M.E., and Flockhart, D.A. (2001). Rifampin is a selective, pleiotropic inducer of drug metabolism genes in human hepatocytes: studies with cDNA and oligonucleotide expression arrays. J. Pharmacol. Exp. Ther. 299, 849–857.10.1016/S0022-3565(24)29202-8Search in Google Scholar

Rebello, S., Zhao, S., Hariry, S., Dahlke, M., Alexander, N., Vapurcuyan, A., Hanna, I., and Jarugula, V. (2012). Intestinal OATP1A2 inhibition as a potential mechanism for the effect of grapefruit juice on aliskiren pharmacokinetics in healthy subjects. Eur. J. Clin. Pharmacol. 68, 697–708.10.1007/s00228-011-1167-4Search in Google Scholar PubMed

Rengelshausen, J., Goggelmann, C., Burhenne, J., Riedel, K.D., Ludwig, J., Weiss, J., Mikus, G., Walter-Sack, I., and Haefeli, W.E. (2003). Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin-clarithromycin interaction. Br. J. Clin. Pharmacol. 56, 32–38.10.1046/j.1365-2125.2003.01824.xSearch in Google Scholar PubMed PubMed Central

Riches, Z., Stanley, E.L., Bloomer, J.C., and Coughtrie, M.W. (2009). Quantitative evaluation of the expression and activity of five major sulfotransferases (SULTs) in human tissues: the SULT “pie”. Drug Metab. Dispos. 37, 2255–2261.10.1124/dmd.109.028399Search in Google Scholar PubMed PubMed Central

Riha, J., Brenner, S., Bohmdorfer, M., Giessrigl, B., Pignitter, M., Schueller, K., Thalhammer, T., Stieger, B., Somoza, V., Szekeres, T., et al. (2014). Resveratrol and its major sulfated conjugates are substrates of organic anion transporting polypeptides (OATPs): impact on growth of ZR-75-1 breast cancer cells. Mol. Nutr. Food Res. 58, 1830–1842.10.1002/mnfr.201400095Search in Google Scholar PubMed

Sai, Y., Kaneko, Y., Ito, S., Mitsuoka, K., Kato, Y., Tamai, I., Artursson, P., and Tsuji, A. (2006). Predominant contribution of organic anion transporting polypeptide OATP-B (OATP2B1) to apical uptake of estrone-3-sulfate by human intestinal Caco-2 cells. Drug Metab. Dispos. 34, 1423–1431.10.1124/dmd.106.009530Search in Google Scholar PubMed

Sasaki, M., Suzuki, H., Ito, K., Abe, T., and Sugiyama, Y. (2002). Transcellular transport of organic anions across a double-transfected Madin-Darby canine kidney II cell monolayer expressing both human organic anion-transporting polypeptide (OATP2/SLC21A6) and Multidrug resistance-associated protein 2 (MRP2/ABCC2). J. Biol. Chem. 277, 6497–6503.10.1074/jbc.M109081200Search in Google Scholar PubMed

Schinkel, A.H., Wagenaar, E., van, D.L., Mol, C.A., and Borst, P. (1995). Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J. Clin. Invest 96, 1698–1705.10.1172/JCI118214Search in Google Scholar

Schwarz, U.I., Gramatte, T., Krappweis, J., Oertel, R., and Kirch, W. (2000). P-glycoprotein inhibitor erythromycin increases oral bioavailability of talinolol in humans. Int. J. Clin. Pharmacol. Ther. 38, 161–167.10.5414/CPP38161Search in Google Scholar

Schwarz, U.I., Seemann, D., Oertel, R., Miehlke, S., Kuhlisch, E., Fromm, M.F., Kim, R.B., Bailey, D.G., and Kirch, W. (2005). Grapefruit juice ingestion significantly reduces talinolol bioavailability. Clin. Pharmacol. Ther. 77, 291–301.10.1016/j.clpt.2004.11.111Search in Google Scholar

Seithel, A., Karlsson, J., Hilgendorf, C., Bjorquist, A., and Ungell, A.L. (2006). Variability in mRNA expression of ABC- and SLC-transporters in human intestinal cells: comparison between human segments and Caco-2 cells. Eur. J. Pharm. Sci. 28, 291–299.10.1016/j.ejps.2006.03.003Search in Google Scholar

Shitara, Y., Hirano, M., Sato, H., and Sugiyama, Y. (2004). Gemfibrozil and its glucuronide inhibit the organic anion transporting polypeptide 2 (OATP2/OATP1B1:SLC21A6)-mediated hepatic uptake and CYP2C8-mediated metabolism of cerivastatin: analysis of the mechanism of the clinically relevant drug-drug interaction between cerivastatin and gemfibrozil. J. Pharmacol. Exp. Ther. 311, 228–236.10.1124/jpet.104.068536Search in Google Scholar

Shu, Y., Sheardown, S.A., Brown, C., Owen, R.P., Zhang, S., Castro, R.A., Ianculescu, A.G., Yue, L., Lo, J.C., Burchard, E.G., et al. (2007). Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. J. Clin. Invest 117, 1422–1431.10.1172/JCI30558Search in Google Scholar

Shugarts, S. and Benet, L.Z. (2009). The role of transporters in the pharmacokinetics of orally administered drugs. Pharm. Res. 26, 2039–2054.10.1007/s11095-009-9924-0Search in Google Scholar

Simoff, I., Karlgren, M., Backlund, M., Lindstrom, A.C., Gaugaz, F.Z., Matsson, P., and Artursson, P. (2016). Complete Knockout of Endogenous Mdr1 (Abcb1) in MDCK Cells by CRISPR-Cas9. J. Pharm. Sci. 105, 1017–1021.10.1016/S0022-3549(15)00171-9Search in Google Scholar

Sjoberg, A., Lutz, M., Tannergren, C., Wingolf, C., Borde, A., and Ungell, A.L. (2013). Comprehensive study on regional human intestinal permeability and prediction of fraction absorbed of drugs using the Ussing chamber technique. Eur. J. Pharm. Sci. 48, 166–180.10.1016/j.ejps.2012.10.007Search in Google Scholar PubMed

Smith, D.E., Clemencon, B., and Hediger, M.A. (2013). Proton-coupled oligopeptide transporter family SLC15: physiological, pharmacological and pathological implications. Mol. Aspects Med. 34, 323–336.10.1016/j.mam.2012.11.003Search in Google Scholar PubMed PubMed Central

Smith, D., Artursson, P., Avdeef, A., Di, L., Ecker, G.F., Faller, B., Houston, J.B., Kansy, M., Kerns, E.H., Kramer, S.D., et al. (2014). Passive lipoidal diffusion and carrier-mediated cell uptake are both important mechanisms of membrane permeation in drug disposition. Mol. Pharm. 11, 1727–1738.10.1021/mp400713vSearch in Google Scholar PubMed

Staudinger, J.L., Woody, S., Sun, M., and Cui, W. (2013). Nuclear-receptor-mediated regulation of drug- and bile-acid-transporter proteins in gut and liver. Drug Metab. Rev. 45, 48–59.10.3109/03602532.2012.748793Search in Google Scholar PubMed PubMed Central

Sugano, K., Kansy, M., Artursson, P., Avdeef, A., Bendels, S., Di, L., Ecker, G.F., Faller, B., Fischer, H., Gerebtzoff, G., et al. (2010). Coexistence of passive and carrier-mediated processes in drug transport. Nat. Rev. Drug Discov. 9, 597–614.10.1038/nrd3187Search in Google Scholar PubMed

Tamai, I. and Nakanishi, T. (2013). OATP transporter-mediated drug absorption and interaction. Curr. Opin. Pharmacol. 13, 859–863.10.1016/j.coph.2013.09.001Search in Google Scholar PubMed

Tamai, I., Nezu, J., Uchino, H., Sai, Y., Oku, A., Shimane, M., and Tsuji, A. (2000). Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. Biochem. Biophys. Res. Commun. 273, 251–260.10.1006/bbrc.2000.2922Search in Google Scholar PubMed

Thomas, V.H., Bhattachar, S., Hitchingham, L., Zocharski, P., Naath, M., Surendran, N., Stoner, C.L., and El-Kattan, A. (2006). The road map to oral bioavailability: an industrial perspective. Expert Opin. Drug Metab. Toxicol. 2, 591–608.10.1517/17425255.2.4.591Search in Google Scholar PubMed

Tirona, R.G. and Kim, R.B. (2005). Nuclear receptors and drug disposition gene regulation. J. Pharm. Sci. 94, 1169–1186.10.1002/jps.20324Search in Google Scholar PubMed

Trdan, L.T., Mrhar, A., Stieger, B., Kullak-Ublick, G.A., Marc, J., Ostanek, B., Zavratnik, A., Kristl, A., Berginc, K., Delic, K., et al. (2012a). Influence of hepatic and intestinal efflux transporters and their genetic variants on the pharmacokinetics and pharmacodynamics of raloxifene in osteoporosis treatment. Transl. Res. 160, 298–308.10.1016/j.trsl.2012.03.002Search in Google Scholar PubMed

Trdan, L.T., Stieger, B., Marc, J., Mrhar, A., Trontelj, J., Zavratnik, A., and Ostanek, B. (2012b). Organic anion transporting polypeptides OATP1B1 and OATP1B3 and their genetic variants influence the pharmacokinetics and pharmacodynamics of raloxifene. J. Transl. Med. 10, 76.10.1186/1479-5876-10-76Search in Google Scholar PubMed PubMed Central

Tubic, M., Wagner, D., Spahn-Langguth, H., Weiler, C., Wanitschke, R., Bocher, W.O., and Langguth, P. (2006). Effects of controlled-release on the pharmacokinetics and absorption characteristics of a compound undergoing intestinal efflux in humans. Eur. J. Pharm. Sci. 29, 231–239.10.1016/j.ejps.2006.04.005Search in Google Scholar PubMed

Tucker, T.G., Milne, A.M., Fournel-Gigleux, S., Fenner, K.S., and Coughtrie, M.W. (2012). Absolute immunoquantification of the expression of ABC transporters P-glycoprotein, breast cancer resistance protein and multidrug resistance-associated protein 2 in human liver and duodenum. Biochem. Pharmacol. 83, 279–285.10.1016/j.bcp.2011.10.017Search in Google Scholar PubMed

Tzvetkov, M.V., dos Santos Pereira, J.N., Meineke, I., Saadatmand, A.R., Stingl, J.C., and Brockmoller, J. (2013). Morphine is a substrate of the organic cation transporter OCT1 and polymorphisms in OCT1 gene affect morphine pharmacokinetics after codeine administration. Biochem. Pharmacol. 86, 666–678.10.1016/j.bcp.2013.06.019Search in Google Scholar PubMed

Ulvestad, M., Skottheim, I.B., Jakobsen, G.S., Bremer, S., Molden, E., Asberg, A., Hjelmesaeth, J., Andersson, T.B., Sandbu, R., and Christensen, H. (2013). Impact of OATP1B1, MDR1, and CYP3A4 expression in liver and intestine on interpatient pharmacokinetic variability of atorvastatin in obese subjects. Clin. Pharmacol. Ther. 93, 275–282.10.1038/clpt.2012.261Search in Google Scholar PubMed

Urquhart, B.L., Tirona, R.G., and Kim, R.B. (2007). Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs. J. Clin. Pharmacol. 47, 566–578.10.1177/0091270007299930Search in Google Scholar PubMed

van de Wetering, K., Zelcer, N., Kuil, A., Feddema, W., Hillebrand, M., Vlaming, M.L., Schinkel, A.H., Beijnen, J.H., and Borst, P. (2007). Multidrug resistance proteins 2 and 3 provide alternative routes for hepatic excretion of morphine-glucuronides. Mol. Pharmacol. 72, 387–394.10.1124/mol.107.035592Search in Google Scholar PubMed

Wang, Z., Pal, D., Patel, A., Kwatra, D., and Mitra, A.K. (2013). Influence of overexpression of efflux proteins on the function and gene expression of endogenous peptide transporters in MDR-transfected MDCKII cell lines. Int. J. Pharm. 441, 40–49.10.1016/j.ijpharm.2012.12.011Search in Google Scholar PubMed PubMed Central

Wang, L., Prasad, B., Salphati, L., Chu, X., Gupta, A., Hop, C.E., Evers, R., and Unadkat, J.D. (2015). Interspecies variability in expression of hepatobiliary transporters across human, dog, monkey, and rat as determined by quantitative proteomics. Drug Metab. Dispos. 43, 367–374.10.1124/dmd.114.061580Search in Google Scholar PubMed

Weitschies, W., Bernsdorf, A., Giessmann, T., Zschiesche, M., Modess, C., Hartmann, V., Mrazek, C., Wegner, D., Nagel, S., and Siegmund, W. (2005). The talinolol double-peak phenomenon is likely caused by presystemic processing after uptake from gut lumen. Pharm. Res. 22, 728–735.10.1007/s11095-005-2588-5Search in Google Scholar PubMed

Weitschies, W., Friedrich, C., Wedemeyer, R.S., Schmidtmann, M., Kosch, O., Kinzig, M., Trahms, L., Sorgel, F., Siegmund, W., Horkovics-Kovats, S., et al. (2008). Bioavailability of amoxicillin and clavulanic acid from extended release tablets depends on intragastric tablet deposition and gastric emptying. Eur. J. Pharm. Biopharm. 70, 641–648.10.1016/j.ejpb.2008.05.011Search in Google Scholar PubMed

Westphal, K., Weinbrenner, A., Zschiesche, M., Franke, G., Knoke, M., Oertel, R., Fritz, P., von, R.O., Warzok, R., Hachenberg, T., et al. (2000). Induction of P-glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: a new type of drug/drug interaction. Clin. Pharmacol. Ther. 68, 345–355.10.1067/mcp.2000.109797Search in Google Scholar PubMed

Wojtal, K.A., Eloranta, J.J., Hruz, P., Gutmann, H., Drewe, J., Staumann, A., Beglinger, C., Fried, M., Kullak-Ublick, G.A., and Vavricka, S.R. (2009). Changes in mRNA expression levels of solute carrier transporters in inflammatory bowel disease patients. Drug Metab. Dispos. 37, 1871–1877.10.1124/dmd.109.027367Search in Google Scholar PubMed

Xu, C., Li, C.Y., and Kong, A.N. (2005). Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch. Pharm. Res. 28, 249–268.10.1007/BF02977789Search in Google Scholar PubMed

Zamek-Gliszczynski, M.J., Chu, X., Polli, J.W., Paine, M.F., and Galetin, A. (2014). Understanding the transport properties of metabolites: case studies and considerations for drug development. Drug Metab. Dispos. 42, 650–664.10.1124/dmd.113.055558Search in Google Scholar PubMed

Zhang, Y. and Benet, L.Z. (2001). The gut as a barrier to drug absorption: combined role of cytochrome P450 3A and P-glycoprotein. Clin. Pharmacokinet. 40, 159–168.10.2165/00003088-200140030-00002Search in Google Scholar PubMed

Zimmermann, C., Gutmann, H., Hruz, P., Gutzwiller, J.P., Beglinger, C., and Drewe, J. (2005). Mapping of multidrug resistance gene 1 and multidrug resistance-associated protein isoform 1 to 5 mRNA expression along the human intestinal tract. Drug Metab. Dispos. 33, 219–224.10.1124/dmd.104.001354Search in Google Scholar PubMed

Zolk, O. and Fromm, M.F. (2011). Transporter-mediated drug uptake and efflux: important determinants of adverse drug reactions. Clin. Pharmacol. Ther. 89, 798–805.10.1038/clpt.2010.354Search in Google Scholar PubMed